Adrenomedullin gene delivery alleviates hypertension and its secondary injuries of cardiovascular system

Human Gene Therapy

Volumn 16, Issue 3, 2005, Pages 372-380

  Wei, Xin ^a   Zhao, Chunxia ^a   Jiang, Jiangang ^a   Li, Juan ^a,b   Xiao, Xiao ^a,b   Dao, Wen Wang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ALBUMIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DRUG EFFECT; GLOMERULOSCLEROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEMODYNAMICS; HYPERTENSION; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PROTEIN URINE LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ADRENOMEDULLIN; ALBUMINURIA; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC VECTORS; HEART; HYPERTENSION; KIDNEY; MALE; ORGAN SIZE; PEPTIDES; RATS; RATS, INBRED SHR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 16344392936     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.372     Document Type: Article

References (37)

1. AURICCHIO, A., HILDINGER, M., O'CONNOR, E., GAO, G.-P., and WILSON, J.M. (2001). Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71-76.
2. CARON, K.M., and SMITHIES, O. (2001). Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. PNAS 98, 615-619.
3. CHAO, J., JIN, L., LIN, K., and CHAO, L. (1997). Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens. Res. 20, 269-277.
4. CINDY, W., ERIC, D., JULIE, C., and LEE, C. (2001). Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. Am. J. Physiol. Ren. Physiol. 280, F964-971.
5. DOBRZYNSKI, E., WANG, C., CHAO J., and CHAO, L. (2000). Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 36, 995-1001.
6. EBARA, T., MIURA, K., OKUMURA, M., MATSUURA, T., KIM, S., YUKIMURA, T., et al. (1994). Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur. J. Pharmacol. 263, 69-73.
7. ELHAWARY, A., POON, J., and PANG, C. (1995). Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin. Br. J. Pharmacol. 115, 1133-1140.
8. FUKUHARA, M., TSUCHIHASHI, T., ABE, I., and FUJISHIMA, M. (1995). Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am. J. Physiol. Ren. Physiol. 269, R1289-1293.
9. HINSON, J.P., KAPAS, S., and SMITH, D.M. (2000). Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21, 138-167.
10. HIRATA, Y., HAYAKAWA, H., SUZUKI, Y., SUZUKI, E., IKENOUCHI, H., KOHMOTO, O., et al. (1995). Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 25, 790-795.
11. ISHIMITSU, T., NISHIKIMI, T., SAITO, Y., KITAMURA, K., ETO, T., KANGAWA, K., et al. (1994). Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. 94, 2158-2161.
12. ISHIYAMA, Y., KITAMURA, K., ICHIKI, Y., NAKAMURA, S., KIDA, O., KANGAWA, K., et al. (1993). Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur. J. Pharmacol. 241, 271-273.
13. JAMES, M., FOTHERBY, M., and POTTER, J. (1994). Microalbuminuria in elderly hypertensives: Reproducibility and relation to clinic and ambulatory blood pressure. J. Hypertens. 12, 309-314.
14. KANO, H., KOHNO, M., YASUNARI, K., YOKOKAWA, K., HORIO T., IKEDA, M., et al. (1996). Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J. Hypertens. 14, 209-213.
15. KITAMURA, K., KANGAWA, K., KAWAMOTO M., ICHIKI, Y., NAKAMURA, S., MATSUO, H., et al. (1993). Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192, 553-560.
16. KITAMURA, K., SAKATA, J., KANGAWA, K., KOJIMA, M., MATSUO, H., and ETO, T. (1994). Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194, 720-725.
17. KOBAYASHI, K., KITAMURA, K., ETOH, T., NAGATOMO, Y., TAKENAGA, M., ISHIKAWA, T., et al. (1996). Increased plasma adrenomedullin levels in chronic congestive heart failure. Am. Heart J. 131, 994-998.
18. KOHNO, M., YOKOKAWA, K., KANO, H., YASUNARI, K., MINAMI, M., HANEHIRA, T., et al. (1997). Adrenomedullin is a potent inhibitor of angiotensin II induced migration of human coronary artery smooth muscle cells. Hypertension 29, 1309-1313.
19. NISHIKIMI, T., KITAMURA, K., SAITO, Y., SHIMADA, K., ISHIMITSU, T., TAKAMIYA, M., et al. (1994). Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 24, 600-604.
20. NISHIKIMI, T., SAITO, Y., KITAMURA, K., ISHIMITSU T., ETO, T., KANGAWA, K., et al. (1995). Increased plasma levels of adrenomedullin in patients with heart failure. J. Am. Coll. Cardiol. 26, 1424-1431.
21. PARKES, D., and MAY, C. (1997). Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br. J. Pharmacol. 120, 1179-1185.
22. POUSSET, F., MASSON, F., CHAVIROVSKAIA, O., ISNARD, R., CARAYON, A., GOLMARD, J., et al. (2000). Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur. Heart J. 21, 1009-1014.
23. RICHARDS, A., NICHOLLS, M., LEWIS, L., and LAINCHBURY, J. (1996). Adrenomedullin. Clin. Sci. (Lond.) 91, 3-16.
24. RICHARDS, A., DOUGHTY, R., NICHOLLS, M., MACMAHON, S., SHARPE, N., MURPHY, J., et al. (2001). Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 37, 1781-1787.
25. ROSSI, M., and PERES, L. (1992). Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy. Am. Heart J. 124, 700-709.
26. SAKATA, J., SHIMOKUBO, T., KITAMURA, K., NAKAMURA, S., KANGAWA, K., MATSUO, H., et al. (1993). Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195, 921-927.
27. SAMSON, W. (1999). Adrenomedullin and the control of fluid and electrolyte homeostasis. Ann. Rev. Physiol. 61, 363-389.
28. SAMULSKI, R., SALLY, M., and MUZYCZKA, N. (1999). Adeno-associated viral vectors. In Development of Human Gene Therapy. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor) pp. 131-172.
29. SHINDO, T., KURIHARA, H., MAEMURA, K., KURIHARA, Y., KUWAKI, T., IZUMIDA, T., et al. (2000). Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 101, 2309-2316.
30. SHIRAI, M., SHIMOUCHI, A., IKEDA, S., NINOMIYA, I., SUNAGAWA, K., KANGAWA, K., et al. (1997). Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats. Br. J. Pharmacol. 121, 679-686.
31. TSURUDA, T., KATO, J., KITAMURA, K., KUWASAKO, K, IMAMURA, T., KOIWAYA, Y., et al. (1998). Adrenomedullin: A possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 31, 505-510.
32. UEHARA, Y., HIRAWA, N., KAWABATA, Y., SUZUKI, T., OHSHIMA, N., OKA, K., et al. (1994). Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension 24, 770-778.
33. VARI, R., ADKINS, S., and SAMSON, W. (1996). Renal effects of adrenomedullin in the rat. Proc. Soc. Exp. Biol. Med. 211, 178-183.
34. WANG, Z., MA, H., LI, J., SUN, L., ZHANG, J., and XIAO, X. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111.
35. XIAO, X., LI, J., and SAMULSKI, R.J. (1998). Production of high-liter recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.
36. YAN, Z., ZHANG, Y., DUAN, D., and ENGELHARDT, J.F. (2000). From the cover: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. PNAS 97, 6715-6721.
37. YANG, J., ZHOU, W., ZHANG, Y., ZIDON, T., RITCHIE, T., and ENGELHARDT, J.F. (1999). Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J. Virol. 73, 9468-9477.